TARSUS PHARMACEUTICALS, INC. (TARS) Total liabilities 2020–2025
TARSUS PHARMACEUTICALS, INC. (TARS) total liabilities at each fiscal year-end, per SEC filings.
$218.7MFY2025 · since FY2020: $6.0M → $218.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $218.7M | +43.5% |
| FY2024 | $152.5M | +122.6% |
| FY2023 | $68.5M | +95.9% |
| FY2022 | $35.0M | +187.1% |
| FY2021 | $12.2M | +103.2% |
| FY2020 | $6.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice